Rosacea Prevalence in General Population - Pilot Study

Completed

• Conditions: Rosacea

• Registration Number: NCT02292836
• Lead Sponsor: Galderma R&D

Brief Summary

The purpose of this study is to test and refine, a subject questionnaire aimed to be used in a general population rosacea prevalence study.

Detailed Description

The study will test the subject questionnaire aimed to be used in a full general population prevalence study to screen potential subjects with rosacea.

Questionnaire will be self-administrated to Dermatology outpatients.

Testing will be performed at the practice of 2 Dermatologists experts in rosacea who will evaluate subjects' answers and propose fine-tuning of the questionnaire content, if needed.

Study Timeline

• Study Start: 2012-08
• Primary Completion: 2013-02
• Study Completion: 2013-02
• Study First Submitted: 2014-10-14
• Status Verified: 2014-11
• Study First Submitted QC: 2014-11-13
• Last Update Submitted: 2014-11-13
• Study First Posted: 2014-11-17
• Last Update Posted: 2014-11-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
sensitivity and specificity of questions	Day 1	sensitivity and specificity of each questionnaire key items by comparing subject answers and investigator assessments, as follows: Sensitivity= True Positive/(True Positive+False Negative); Specificity= True Negative/ (False Positive+True Negative)

Trial Locations

Locations (2)

Jerry TAN; 🇨🇦 Windsor, Ontario, Canada

Mats BERG; 🇸🇪 Eskilstuna, Sweden